#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Turner's syndrome Chronic inflammatory demyelinating polyradiculoneuropathy Cerebral amyloid angiopathy Thymic carcinoma Chronic hepatitis B Arteriovenous malformation Immunodeficiency Congenital nephrogenic diabetes insipidus Cerebral arteriovenous malformation haemorrhagic Bone marrow disorder Acute on chronic liver failure Cytomegalovirus infection Non-Hodgkin's lymphoma refractory Progressive supranuclear palsy Squamous cell carcinoma of the hypopharynx More trials…

    Learn about Rare Diseases

    Castleman’s disease Marginal zone lymphoma – Basic Information Hereditary ataxia – Diagnostics Mantle cell lymphoma stage IV – Treatment Familial haemophagocytic lymphohistiocytosis Glomerulonephritis rapidly progressive – Life with Disease Methylmalonic acidaemia – Basic Information Uterine leiomyosarcoma – Trials in Disease Synovial sarcoma – Basic Information Hepatoblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Itacitinib Eftrenonacog Alfa Minoxidil Glycerol Amsacrine Lactose Monohydrate ROPINIROLE Mps-106 Flortaucipir (18F) Vo659 Propafenone Hydrochloride Ianalumab Tislelizumab Regorafenib Dantrolene Sodium Tenofovir Disoproxil Fumarate HYDROMORPHONE HYDROCHLORIDE Vorasidenib Envudeucitinib Idursulfase More therapies…

    Learn about Your Condition

    Thromboangiitis obliterans Hepatocellular carcinoma Testicular leiomyosarcoma Vitamin D deficiency Chondrosarcoma Trisomy 21 Mitochondrial DNA depletion Glomerulonephritis chronic Injection site pain Dyspnoea Hypotension Breast angiosarcoma Placenta praevia Leukoencephalopathy Oxygen therapy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • A study to evaluate if atorvastatin prevents gallstones in patients undergoing bariatric surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Atorvastatin
    The Netherlands

  • Study of the effect of metyrapone in patients with mild Cushing syndrome caused by primary bilateral macronodular adrenal hyperplasia

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Metyrapone
    France

  • Study of the effectiveness and safety of alpha-lipoic acid and benfotiamine for the treatment of symptoms in patients with diabetic neuropathy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Benfotiamine
    Hungary

  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Cachexia
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Ponsegromab
    Belgium Bulgaria France Germany Italy Poland +2

  • Study of Fecal Microbiota Transplantation Compared to Sham Treatment for Patients with Primary Sclerosing Cholangitis

    Not yet recruiting

    4 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France

  • A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • SC0062
    • Dapagliflozin
    Denmark Finland The Netherlands
Previous Page
1 … 25 26 27 28 29 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!